维普期刊资源整合服务平台（V6.5）

236篇 您的检索式：作者名="YEAP BY"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma 显示文摘	Gordon G J Dung L Yeap BY	2009	J Natl Cancer Inst2009，101，：	1
2	Development of central nervous system metastases in patients with advanced non -small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib显示文摘	Heon S Yeap BY Britt GJ	2010	Clin Cancer Res2010，16，23：	1
3	Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK显示文摘	Shaw AT Yeap BY Mino-Kenudson M	2009	J Clin Oncol2009，27，26：	1
4	Phase II clinical trial of chemotherapy - naive patients ≥ 70years of age treated with erlotinib for advanced non - small - cell lung cancer 显示文摘	Jackman DM Yeap BY Lindeman NI	2007	J Clin Oncol2007，25，：	1
5	High risk of brain metastases in surgically staged ⅢA non small-cell lung cancer patients treated with surgery ,chemotherapy ,and radiationJ显示文摘	Mamon HJ Yeap BY Janne PA	2005	Clin Oncol2005，23，7：	1
6	Phase II clinical trial of chemotherapy-naive patients>or70 years of age treated with erlotinib for advanced non-small-cell lung cancer显示文摘	Jackman DM Yeap BY Ni LM	2007	J Clin Oncol2007，25，7：	1
7	Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK显示文摘	Shaw AT Yeap BY Mino-Kenudson M	2009	J Clin Onco2009，27，26：	1
8	Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement:a retrospective analysis显示文摘	Shaw AT Yeap BY Solomon BJ		0，，：	1
9	Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK显示文摘	Shaw AT Yeap BY Mino-Kenudson M		0，，26：	1
10	Outcomes of patients with advanced non-small-cell lung cancer treated with gefitinib (ZD1839, 'lressa')on an expanded access study显示文摘	JANNE PA GURUBHAGAVATULA S YEAP BY	2004	Lung Cancer2004，44，2：	1
11	Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement:a retrospective analysis显示文摘	Shaw AT Yeap BY Solomon BJ	2011	Lancet Oncol2011，12，：	1
12	Clinical fea- tures and outcome of patients with non-small-cell lung cancer who harbor EMIA-ALK 显示文摘	Shaw AT Yeap BY Mino-Kenudson M	2009	J Clin Oncol2009，27，26：	1
13	Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK显示文摘	Shaw AT Yeap BY Mino-Kenudsen M	2009	J Clin Oncol2009，27，26：	1
14	Donor-derived second hematologic malignancies after cord blood transplantation显示文摘	Ballen KK Cutler C Yeap BY	2010	Biol Blood Marrow Transplant2010，16，7：	1
15	Development of central nervous Sys- tem metastases in patients with advanced non-small cell lung cancel and somatic EGFR mutations treated with gefitinib or erlotinib显示文摘	Heon S Yeap BY Britt GJ	2010	Cli~ Cancer Res2010，16，23：	1
16	Phase II clinical trial of chemotherapy-naive patients > 70 years of age treated with erlotinib for advanced non small-cell lung cancer显示文摘	Jackman DM Yeap BY Lindeman NI	2007	J Clin Oneol2007，25，7：	1
17	Clinical features and outcome of patients with non-small cell lung cancer who harbor EMIA-ALK显示文摘	Shaw AT Yeap BY Mino-Kenudson M	2009	J Clin Oncol2009，27，26：	1
18	Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in nonsmall cell lung cancer patients treated with gefitinib or erlotinib显示文摘	Jackman DM Yeap BY Sequist LV		0，，13：	1
19	Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma显示文摘	Jackman DM Kindler HL Yeap BY		0，，4：	1
20	The impact of initial gefitinib ol erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutations 显示文摘	Heon S Yeap BY Lindeman NI	2012	Clin Cancer IRes2012，18，16：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示